“COST-EFFECTIVENESS ANALYSIS OF AVELUMAB TREATMENT FOR PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA”. Voprosy Onkologii, vol. 66, no. 2, Feb. 2020, pp. 109-1, https://doi.org/10.37469/0507-3758-2020-66-2-109-119.